Fig. 4From: Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathwayConstitutively active β-catenin binding activity was observed in nuclear extracts from MG-63, U2OS and HOS cells. In all cells, compared with untreated control, both celecoxib and cisplatin treatment obviously decreased β-catenin binding activity, meanwhile, significant down-regulation of β-catenin binding activity was displayed in MG-63 and U2OS cellsBack to article page